Multiple sclerosis patients lacking oligoclonal bands in the cerebrospinal fluid have less global and regional brain atrophy

Journal of Neuroimmunology

Volumn 274, Issue 1-2, 2014, Pages 149-154

  Ferreira, Daniel ^a   Voevodskaya, Olga ^a   Imrell, Kerstin ^a   Stawiarz, Leszek ^a   Spulber, Gabriela ^a   Wahlund, Lars Olof ^a   Hillert, Jan ^a   Westman, Eric ^a   Karrenbauer, Virginija Danylaité ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Brain atrophy; Cerebrospinal fluid; MRI; Multiple Esclerosis; Multivariate analyses; Oligoclonal bands

Indexed keywords

OLIGOCLONAL BAND;

ADULT; ARTICLE; BASAL GANGLION; BRAIN ATROPHY; BRAIN SIZE; BRAIN STEM; CEREBELLUM; CEREBROSPINAL FLUID LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; CORPUS CALLOSUM; DIENCEPHALON; DISEASE SEVERITY; FEMALE; FOLLOW UP; GRAY MATTER; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN ANALYSIS; WHITE MATTER LESION;

BRAIN ATROPHY; CEREBROSPINAL FLUID; MRI; MULTIPLE ESCLEROSIS; MULTIVARIATE ANALYSES; OLIGOCLONAL BANDS;

ADULT; ATROPHY; BRAIN; BRAIN DISEASES; DISABILITY EVALUATION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; MULTIVARIATE ANALYSIS; OLIGOCLONAL BANDS;

EID: 84906940305     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2014.06.010     Document Type: Article

References (32)

1. Andersen O. From the Gothenburg cohort to the Swedish multiple sclerosis registry. Acta Neurol. Scand. Suppl. 2012, 126:13-19.
2. Andersson M., Alvarez-Cermeño J., Bernardi G., Cogato I., Fredman P., Frederiksen J., Fredrikson S., Gallo P., Grimaldi L.M., Grønning M., Keir G., Lamers K., Link H., Magalhaes A., Massaro A.R., Öhman S., Reiber H., Rönnbäck L., Schluep M., Schuller E., Sindic C.J.M., Thompson E.J., Trojano M., Wurster U. Cerebrospinal fluid in the diagnosis of multiple sclerosis: A consensus report. J. Neurol. Neurosurg. Psychiatry 1994, 57:897-902.
3. Benedict R.H.B., Bruce J.M., Dwyer M.G., Abdelrahman N., Hussein S., Weinstock-Guttman B., Garg N., Munschauer F., Zivadinov R. Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis. JAMA Neurol. 2006, 63:1301-1306.
4. Benjelloun N., Charriaut-Marlangue C., Hantaz-Ambroise D., Ménard A., Pierig R., Alliel P., Rieger F. Induction of cell death in rat brain by a gliotoxic factor from cerebrospinal fluid in multiple sclerosis. Cell. Mol. Biol. 2002, 48:205-212.
5. Calabrese M., De Stefano N., Atzori M., Bernardi V., Mattisi I., Barachino L., Morra A., Rinaldi L., Romualdi C., Perini P., Battistin L., Gallo P. Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis. Arch. Neurol. 2007, 64:1416-1422.
6. Ceccarelli A., Bakshi R., Neema M. MRI in multiple sclerosis: a review of the current literature. Curr. Opin. Neurol. 2012, 25:402-409.
7. Filippi M., Rocca M.A. MR imaging of multiple sclerosis. Radiology 2011, 259:659-681.
8. Fukazawa T., Kikuchi S., Sasaki H., Hamada K., Hamada T., Miyasaka K., Tashiro K. The significance of oligoclonal bands in multiple sclerosis in Japan: relevance of immunogenetic backgrounds. J. Neurol. Sci. 1998, 158:209-214.
9. García-Lorenzo D., Francis S., Narayanan S., Arnold D.L., Collins D.L. Review of automatic segmentation methods of multiple sclerosis white matter lesions on conventional magnetic resonance imaging. Med. Image Anal. 2013, 17:1-18.
10. Huttner H.B., Schellinger P.D., Struffert T., Richter G., Engelhorn T., Bassemir T., Mäurer M., Garcia M., Schwab S., Köhrmann M., Doerfler A. MRI criteria in MS patients with negative and positive oligoclonal bands: equal fulfillment of Barkhof's criteria but different lesion patterns. J. Neurol. 2009, 256:1121-1125.
11. Imrell K., Landtblom A.-M., Hillert J., Masterman T. Multiple sclerosis with and without CSF bands: clinically indistinguishable but immunogenetically distinct. Neurology 2006, 67:1062-1064.
12. Imrell K., Greiner E., Hillert J., Masterman T. HLA-DRB115 and cerebrospinal-fluid-specific oligoclonal immunoglobulin G bands lower age at attainment of important disease milestones in multiple sclerosis. J. Neuroimmunol. 2009, 210:128-130.
13. Jack C.J., Twomey C., Zinsmeister A., Sharbrough F.W., Petersen R., Cascino G. Anterior temporal lobes and hippocampal formations: normative volumetric measurements from mr images in young adults. Radiology 1989, 172:549-554.
14. Karrenbauer V.D., Prejs R., Masterman T., Hillert J., Glaser A., Imrell K. Impact of cerebrospinal-fluid oligoclonal immunoglobulin bands and HLA-DRB1 risk alleles on brain magnetic-resonance-imaging lesion load in Swedish multiple sclerosis patients. J. Neuroimmunol. 2013, 254:170-173.
15. Kostulas V., Link H., Lefvert A.K. Oligoclonal IgG bands in cerebrospinal fluid. Principles for demonstration and interpretation based on findings in 1114 neurological patients. Arch. Neurol. 1987, 44:1041-1044.
16. Mandler R.N., Dencoff J.D., Midani F., Ford C.C., Ahmed W., Rosenberg G.A. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in cerebrospinal fluid differ in multiple sclerosis and Devic's neuromyelitis optica. Brain 2001, 124:493-498.
17. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., Lublin F.D., McFarland H.F., Paty D.W., Polman C.H., Reingold S.C., Sandberg-Wollheim M., Sibley W., Thompson A., van den Noort S., Weinshenker B.Y., Wolinsky J.S. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 2001, 50:121-127.
18. Minagar A., Barnett M., Benedict R., Pelletier D., Pirko I., Sahraian M., Frohman E., Zivadinov R. The thalamus and multiple sclerosis. Modern views on pathologic, imaging, and clinical aspects. Neurology 2013, 80:210-219.
19. Nakashima I., Fujihara K., Misu T., Okita N., Takase S., Itoyama Y. Significant correlation between IL-10 levels and IgG indices in the cerebrospinal fluid of patients with multiple sclerosis. J. Neuroimmunol. 2000, 111:64-67.
20. Nakashima I., Fujihara K., Misu T., Fujimori J., Sato S., Takase S., Itoyama Y. A comparative study of Japanese multiple sclerosis patients with and without oligoclonal IgG bands. Mult. Scler. 2002, 8:459-462.
21. Nakashima I., Fujihara K., Miyazawa H., Misu T., Fujimori J., Sato S., Itoyama Y. Relevance of callosal and periventricular MRI lesions to oligoclonal bands in multiple sclerosis. Acta Neurol. Scand. 2006, 113:125-131.
22. Olsson T., Kostulas V., Link H. Improved detection of oligoclonal lgg in cerebrospinal fluid by isoelectric focusing in agarose, double-antibody peroxidase labeling, and avidin-biotin amplification. Clin. Chem. 1984, 30:1246-1249.
23. Petzold A. Intrathecal oligoclonal IgG synthesis in multiple sclerosis. J. Neuroimmunol. 2013, 262:1-10.
24. Pichiecchio A., Tavazzi E., Maccabelli G., Ponzio M., Romani A., Schiappacassa R., Poloni G.U., Franciotta D., Roccatagliata L., Bergamaschi R., Bastianello S. MR peri-CSF lesions and CSF oligoclonal bands in Italian multiple sclerosis patients. Acta Neurol. Scand. 2009, 120:242-245.
25. Polman C.H., Reingold S.C., Edan G., Filippi M., Hartung H., Kappos L., Lublin F.D., Metz L.M., Mcfarland H.F., O'Connor P.W., Sandberg-wollheim M., Thompson A.J., Weinshenker B.G., Wolinsky J.S. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann. Neurol. 2005, 58:840-846.
26. Polman C.H., Reingold S.C., Banwell B., Clanet M., Cohen J.A., Filippi M., Fujihara K., Havrdova E., Hutchinson M., Kappos L., Lublin F.D., Montalban X., O'Connor P., Sandberg-Wollheim M., Thompson A.J., Waubant E., Weinshenker B., Wolinsky J.S. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann. Neurol. 2011, 69:292-302.
27. Ramasamy D.P., Benedict R.H.B., Cox J.L., Fritz D., Abdelrahman N., Hussein S., Minagar A., Dwyer M.G., Zivadinov R. Extent of cerebellum, subcortical and cortical atrophy in patients with MS: a case-control study. J. Neurol. Sci. 2009, 282:47-54.
28. Rocca M.A., Messina R., Filippi M. Multiple sclerosis imaging: recent advances. J. Neurol. 2013, 260:929-935.
29. Simmons A., Westman E., Muehlboeck S., Mecocci P., Vellas B., Tsolaki M., Kłoszewska I., Wahlund L.-O., Soininen H., Lovestone S., Evans A., Spenger C. MRI measures of Alzheimer's disease and the AddNeuroMed study. Ann. N. Y. Acad. Sci. 2009, 1180:47-55.
30. Westman E., Muehlboeck J.S., Simmons A. Combining MRI and CSF measures for classification of Alzheimer's disease and prediction of mild cognitive impairment conversion. NeuroImage 2012, 62:229-238.
31. Westman E., Aguilar C., Muehlboeck J.S., Simmons A. Regional magnetic resonance imaging measures for multivariate analysis in Alzheimer's disease and mild cognitive impairment. Brain Topogr. 2013, 26:9-23.
32. Zeman A.Z.J., Kidd D., Mclean B.N., Kelly M.A., Francis D.A., Miller D.H., Kendall B.E., Rudge P., Thompson E., McDonald W. A study of oligoclonal band negative multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 1996, 60:27-30.